Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY-NC-ND 4.0Cardiovascular Diabetology

Association of the cholesterol, high-density lipoprotein, and glucose (CHG) index with mortality after acute myocardial infarction: evidence from two large prospective cohorts

5 affiliations
  1. 1Cardiometabolic Medicine Center, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  2. 2Coronary Heart Disease Center, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  3. 3State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037 China
  4. 4Emergency and Critical Care Center, Fuwai Hospital, National Center for Cardiovascular Diseases of China, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  5. 5Bengbu First People’s Hospital, Bengbu, Anhui China

Abstract

Background: Patients with acute myocardial infarction (AMI) continue to face a considerable risk of death, even in the era of contemporary reperfusion and secondary prevention. Metabolic abnormalities may partly explain this residual risk. The cholesterol, high-density lipoprotein, and glucose (CHG) index, calculated as Ln{[total cholesterol (TC, mg/dL) × fasting blood glucose (FBG, mg/dL)]/[2 × high-density lipoprotein cholesterol (HDL-C, mg/dL)]}, is a recently proposed marker integrating lipid and glucose metabolism. We primarily aimed to examine the association between the CHG index and mortality in patients with AMI.

Methods: We analyzed two prospective cohorts, including 8,782 patients with AMI from the China Acute Myocardial Infarction (CAMI) registry and 3,466 AMI patients undergoing percutaneous coronary intervention at Fuwai Hospital. Outcomes included in-hospital, 1-year, and 2-year all-cause mortality in the CAMI cohort, and all-cause mortality in the Fuwai Hospital cohort. Associations between the CHG index and mortality were assessed using Cox proportional hazards models and restricted cubic splines. Discrimination, reclassification, and decision curve analyses were performed as secondary exploratory analyses.

Results: In the CAMI cohort, higher CHG levels were associated with a graded increase in mortality risk. After multivariable adjustment, patients in the highest CHG tertile had higher risks of in-hospital mortality [hazard ratio (HR): 2.66, 95% confidence interval (CI): 1.63–4.32], 1-year mortality (HR: 2.44, 95% CI: 1.81–3.30), and 2-year mortality (HR: 2.41, 95% CI: 1.78–3.25) compared with those in the lowest tertile. Consistent findings were observed in the Fuwai Hospital cohort, in which the highest CHG tertile was associated with higher all-cause mortality after multivariable adjustment (HR: 2.16, 95% CI: 1.28–3.63). Restricted cubic spline analyses showed an approximately linear relationship between CHG and mortality. In secondary exploratory analyses, the CHG index yielded higher areas under the curve than the TyG index in both cohorts. In the CAMI cohort, adding CHG to the Global Registry of Acute Coronary Events (GRACE) score resulted in statistically significant but modest improvements in discrimination and reclassification and increased the net benefit in decision curve analysis.

Conclusions: A higher CHG index was consistently associated with increased mortality risk after AMI across two independent cohorts, although its clinical utility requires further evaluation.

Graphical abstract:

Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12933-026-03332-8.

Related

  1. Estimated small dense low-density lipoprotein cholesterol and incident myocardial infarction in patients undergoing dialysis: a nationwide cohort study.
    Byung Sik Kim, Hyun-Jin Kim, Jiyeong Kim +2
    Annals of medicinePeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  2. Association between the cholesterol-high-density lipoprotein-glucose index and the incidence of new-onset diabetes in patients with chronic gastrointestinal diseases: A prospective cohort study.
    Liyan Lv, Juhua Wu, Xiaoqing Lin +2
    Journal of diabetes investigationPeer-reviewedCC BY-NC-NDFull textEndocrinology & metabolismEurope PMC
  3. Lipoprotein(a) After Myocardial Infarction: Residual Risk, Measurement, and the Unresolved Therapeutic Question
    Alexandra Gogan, Samuel Ardelean, Daniel Rus +4
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Simultaneous two-vessel occlusion causing ST-segment elevation myocardial infarction associated with elevated lipoprotein (a): A case report
    Shingo Watanabe, Junichi Onuma, Ryota Ishida +2
    Journal of Cardiology CasesPeer-reviewedLicence not statedFull textCardiovascular medicinePMC
  5. Small dense low-density lipoprotein cholesterol and risk of cardiovascular events in general adults: a systematic review and meta-analysis of prospective studies.
    Tran Quang Duc, Khanh Nguyen Di, Dang Dang Khoa
    BMJ openPeer-reviewedCC BY-NCFull textSurgery & anaesthesiaEurope PMCCrossref
BibTeX
@article{chen2026association,
  title = {{Association of the cholesterol, high-density lipoprotein, and glucose (CHG) index with mortality after acute myocardial infarction: evidence from two large prospective cohorts}},
  author = {Xinyue Chen and Rui Fu and Yanjun Song and Deyi Yang and Yuejin Yang and Kefei Dou},
  journal = {Cardiovascular Diabetology},
  year = {2026},
  month = aug,
  doi = {10.1186/s12933-026-03332-8},
  url = {https://doi.org/10.1186/s12933-026-03332-8},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Association of the cholesterol, high-density lipoprotein, and glucose (CHG) index with mortality after acute myocardial infarction: evidence from two large prospective cohorts
AU  - Xinyue Chen
AU  - Rui Fu
AU  - Yanjun Song
AU  - Deyi Yang
AU  - Yuejin Yang
AU  - Kefei Dou
PY  - 2026
DA  - 2026/08/16
JO  - Cardiovascular Diabetology
DO  - 10.1186/s12933-026-03332-8
UR  - https://doi.org/10.1186/s12933-026-03332-8
AB  - Background: Patients with acute myocardial infarction (AMI) continue to face a considerable risk of death, even in the era of contemporary reperfusion and secondary prevention. Metabolic abnormalities may partly explain this residual risk. The cholesterol, high-density lipoprotein, and glucose (CHG) index, calculated as Ln{[total cholesterol (TC, mg/dL) × fasting blood glucose (FBG, mg/dL)]/[2 × high-density lipoprotein cholesterol (HDL-C, mg/dL)]}, is a recently proposed marker integrating lipid and glucose metabolism. We primarily aimed to examine the association between the CHG index and mortality in patients with AMI.  Methods: We analyzed two prospective cohorts, including 8,782 patients with AMI from the China Acute Myocardial Infarction (CAMI) registry and 3,466 AMI patients undergoing percutaneous coronary intervention at Fuwai Hospital. Outcomes included in-hospital, 1-year, and 2-year all-cause mortality in the CAMI cohort, and all-cause mortality in the Fuwai Hospital cohort. Associations between the CHG index and mortality were assessed using Cox proportional hazards models and restricted cubic splines. Discrimination, reclassification, and decision curve analyses were performed as secondary exploratory analyses.  Results: In the CAMI cohort, higher CHG levels were associated with a graded increase in mortality risk. After multivariable adjustment, patients in the highest CHG tertile had higher risks of in-hospital mortality [hazard ratio (HR): 2.66, 95% confidence interval (CI): 1.63–4.32], 1-year mortality (HR: 2.44, 95% CI: 1.81–3.30), and 2-year mortality (HR: 2.41, 95% CI: 1.78–3.25) compared with those in the lowest tertile. Consistent findings were observed in the Fuwai Hospital cohort, in which the highest CHG tertile was associated with higher all-cause mortality after multivariable adjustment (HR: 2.16, 95% CI: 1.28–3.63). Restricted cubic spline analyses showed an approximately linear relationship between CHG and mortality. In secondary exploratory analyses, the CHG index yielded higher areas under the curve than the TyG index in both cohorts. In the CAMI cohort, adding CHG to the Global Registry of Acute Coronary Events (GRACE) score resulted in statistically significant but modest improvements in discrimination and reclassification and increased the net benefit in decision curve analysis.  Conclusions: A higher CHG index was consistently associated with increased mortality risk after AMI across two independent cohorts, although its clinical utility requires further evaluation.  Graphical abstract:  Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12933-026-03332-8.
SN  - 1475-2840
ER  -